Abstract:Background TBX1 (T-box transcription factor 1) is a major candidate gene that likely contributes to the etiology of velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS). Although the haploinsufficiency of TBX1 in both mice and humans results in congenital cardiac malformations, little has been elucidated about its upstream regulation. We aimed to explore the transcriptional regulation and dysregulation of TBX1 . Methods Different TBX1 promoter reporters were constructed. Luciferase assays and electrophoretic mobility shift assays (EMSAs) were used to identify a cis -regulatory element within the TBX1 promoter region and its trans -acting factor. The expression of proteins was identified by immunohistochemistry and immunofluorescence. Variants in the cis -regulatory element were screened in conotruncal defect (CTD) patients. In vitro functional assays were performed to show the effects of the variants found in CTD patients on the transactivation of TBX1 . Results We identified a cis -regulatory element within intron 1 of TBX1 that was found to be responsive to GATA6 (GATA binding protein 6), a transcription factor crucial for cardiogenesis. The expression patterns of GATA6 and TBX1 overlapped in the pharyngeal arches of human embryos. Transfection experiments and EMSA indicated that GATA6 could activate the transcription of TBX1 by directly binding with its GATA cis -regulatory element in vitro. Furthermore, sequencing analyses of 195 sporadic CTD patients without the 22q11.2 deletion or duplication identified 3 variants (NC_000022.11:g.19756832C > G, NC_000022.11:g.19756845C > T, and NC_000022.11:g. 19756902G > T) in the non-coding cis -regulatory element of TBX1 . Luciferase assays showed that all 3 variants led to reduced transcription of TBX1 when incubated with GATA6. Conclusions Our findings showed that TBX1 might be a direct transcriptional target of GATA6, and variants in the non-coding cis -regulatory element of TBX1 disrupted GATA6-mediated transactivation.

TBX20-an important target gene for the prevention and treatment of cardiovascular diseases

TBX5 Mutations Contribute to Early-Onset Atrial Fibrillation in Chinese and Caucasians.

The Role of Tbx20 in Cardiovascular Development and Function

A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease.

TBX1 Loss-of-function Mutation Contributes to Congenital Conotruncal Defects

TBX20 Loss-of-function Mutation Responsible for Familial Tetralogy of Fallot or Sporadic Persistent Truncus Arteriosus.

Abstract P331: Upregulated TBX1 by Genetic Variants Are Associated with Human Congenital Heart Disease

Dual Transcriptional Activator and Repressor Roles of TBX20 Regulate Adult Cardiac Structure and Function.

Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function.

TBX20 Loss-of-function Mutation Contributes to Double Outlet Right Ventricle.

A New TBX5 Loss-of-Function Mutation Contributes to Congenital Heart Defect and Atrioventricular Block

A Novel Tbx20 Loss-Of-Function Mutation Contributes to Adult-Onset Dilated Cardiomyopathy or Congenital Atrial Septal Defect

A Novel Variant in TBX20 (p.d176n) Identified by Whole-Exome Sequencing in Combination with a Congenital Heart Disease Related Gene Filter is Associated with Familial Atrial Septal Defect

Kctd10 Regulates Heart Morphogenesis by Repressing the Transcriptional Activity of Tbx5a in Zebrafish

Abstract 14951: Discovery of a Novel Angiogenic Factor TBX20

A Novel Tbx5 Mutation Predisposes To Familial Cardiac Septal Defects And Atrial Fibrillation As Well As Bicuspid Aortic Valve

The TBX1/miR-193a-3p/TGF-β2 Axis Mediates CHD by Promoting Ferroptosis

Mild Decrease in TBX20 Promoter Activity is a Potentially Protective Factor Against Congenital Heart Defects in the Han Chinese Population.

MiR-10a and MiR-10b Target the 3′-Untranslated Region of TBX5 to Repress Its Expression

Variants in a Cis-Regulatory Element of TBX1 in Conotruncal Heart Defect Patients Impair GATA6-mediated Transactivation.